Open AccessThirty-Day Mortality After Curative and Palliative Anti-Cancer Treatment: Data Interpretation and Lessons for Clinical Implementation
Author(s) -
Emad Tashkandi,
Bassam Basulaiman,
Waleed Alghareeb,
F. Ben Hamadi,
Anas S. AlGhamdi,
Faez Albabakri,
Redhwan Alshabi,
Mohammad Jaffal,
Abdulrahman Albaradie,
Ruqayya Azher
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s277924
Subject(s) - medicine , cancer , breast cancer , observational study , palliative care , obesity , retrospective cohort study , diabetes mellitus , intensive care medicine , endocrinology , nursing
Despite advancements in cancer therapeutics, mortality and morbidity due to anti-cancer treatments still occur but are not frequently reported. We aimed to report the 30-day mortality and morbidity of all curative and palliative anti-cancer treatments.